| HYJUAN Shenzhen Nikeli Technology Co., Ltd.
97105679 02 Nov 2021 | on 29 Nov 2022
| Chandeliers; Downlights; Accent lights for indoor use; Ceiling lights;... Class 011 Class 011 Environmental Control Instrument Products (lighting,heating,cooling,cooking) The wording Hyjuan has no meaning in a foreign language. | | | HYJUVENATE IV THERAPY HyJuvenate IV Therapy LLC
90748858 02 Jun 2021 | on 04 Oct 2022
| Intravenous (IV) hydration therapy services Class 044 Class 044 Medical, Beauty & Agricultural Services HYJUVENATE INTRAVENOUS THERAPY | | | HYJURNY Bristol-Myers Squibb Company
97566239 26 Aug 2022 | on 20 Aug 2024 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use | | | HYJUTSA Glaxo Group Limited
86303634 09 Jun 2014 | on 29 Jan 2018 | Pharmaceutical preparations and substances for the treatment of damage... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines | | 
